Canada’s regulatory approach to drugs for rare diseases: orphan drugs (English, HTML)
Canada’s regulatory approach to drugs for rare diseases: orphan drugs: English HTML file. From Health Canada, updated Dec 2023. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2023-12-02
Canada's regulatory approach: Drugs for rare diseases are authorized for sale in Canada under the Food and Drugs Act and Part C of the Food and Drug Regulations.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file